The RANKL-RANK Story

Gerontology - Tập 61 Số 6 - Trang 534-542 - 2015
Vanja Nagy1, Josef Penninger
1Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria

Tóm tắt

Receptor activator of nuclear factor κB (RANK) and its ligand (RANKL) have originally been described for their key roles in bone metabolism and the immune system. Subsequently, it has been shown that the RANKL-RANK system is critical in the formation of mammary epithelia in lactating females and the thermoregulation of the central nervous system. RANKL and RANK are under the tight control of the female sex hormones estradiol and progesterone. A reduction of the circulating female sex hormones leading to an increase in RANKL-RANK signaling is the leading cause of osteoporosis in postmenopausal women. Denosumab, a human monoclonal anti-RANKL antibody, has been approved for the treatment of postmenopausal osteoporosis, where it is showing great promise. In addition, RANKL-RANK signaling also plays a critical role in other bone pathologies, bone metastasis or hormone-driven breast cancer. This review will highlight some of the functions of RANKL-RANK in bone turnover, the immune system and brain with a focus on the regulatory role of the female sex hormones.

Từ khóa


Tài liệu tham khảo

10.1126/science.289.5484.1501

10.1126/science.289.5484.1504

10.1007/BF02409454

10.1016/S0092-8674(00)81569-X

10.1006/bbrc.1998.9788

10.1016/S0092-8674(00)80209-3

10.1210/endo.139.3.5837

10.1074/jbc.272.40.25190

10.1038/36593

10.1038/46303

10.1038/16852

10.1146/annurev.immunol.24.021605.090646

10.1038/nature08596

10.1073/pnas.1400544111

10.1074/jbc.M606656200

10.1016/j.ccr.2005.04.013

10.1182/blood.V99.1.111

10.1016/j.molmed.2005.11.007

10.1038/nm.2452

10.1074/jbc.M202009200

10.1101/gad.13.8.1015

10.1046/j.1365-2443.1999.00265.x

10.1016/S0014-5793(00)02231-6

10.1126/science.7939685

10.1038/nm1197-1285

10.1016/S1097-2765(00)80232-4

10.1056/NEJMoa013096

10.1101/gad.12.9.1260

10.1006/bbrc.1998.8697

10.1016/j.ajhg.2008.06.015

10.1101/gad.13.18.2412

10.4049/jimmunol.1102063

10.2353/ajpath.2006.060180

10.1182/blood.V98.13.3534

10.1016/j.immuni.2008.06.015

10.1126/science.1159407

10.1172/JCI28775

10.1002/jbmr.5650060114

10.1002/jbmr.5650040106

10.1002/jbmr.5650060212

10.1210/endo-123-3-1504

10.1196/annals.1346.019

10.7150/ijbs.4614

10.1016/j.humpath.2011.05.005

10.1056/NEJM199502023320506

10.1002/jbmr.5650110802

10.1016/S8756-3282(02)00953-5

10.1210/endo.140.9.7131

10.1172/JCI117995

10.1016/S0092-8674(02)08100-X

10.1038/nm1096-1132

10.1084/jem.186.4.489

10.1172/JCI11066

10.1073/pnas.1533207100

10.1016/S0092-8674(00)00103-3

10.1210/edrv.18.6.0319

10.1073/pnas.0915148107

10.1096/fj.10-157982

10.1038/nature09027

10.1126/scitranslmed.3005654

10.1073/pnas.1732707100

10.1038/nature09387

10.1016/S8756-3282(99)00214-8

10.1016/j.prostaglandins.2005.01.001

10.1038/nature04524

10.1001/jama.288.3.321

10.1016/S0140-6736(03)14065-2

10.1056/NEJMoa0809493

10.1200/JCO.2010.29.7101

10.1111/j.1464-410X.2010.09236.x

10.1200/JCO.2010.31.3304

10.4252/wjsc.v6.i3.322

10.1097/CCO.0b013e328354c129

10.1016/j.tem.2011.02.007

10.1038/nature09495

10.1530/EJE-11-0454

10.1038/nm1518

10.4049/jimmunol.179.11.7497

Thông tin
Thông tin xuất bản

Gerontology

Tập 61 Số 6

534-542

Thông tin tác giả